Outcomes of treatment of faecal incontinence with sacral nerve stimulation - a Finnish multicentre study.


Journal

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
ISSN: 1463-1318
Titre abrégé: Colorectal Dis
Pays: England
ID NLM: 100883611

Informations de publication

Date de publication:
01 2019
Historique:
received: 11 06 2018
accepted: 23 07 2018
pubmed: 8 9 2018
medline: 2 4 2020
entrez: 8 9 2018
Statut: ppublish

Résumé

The aim of this multicentre study is to report the results of sacral nerve stimulation (SNS) treatment for faecal incontinence (FI) in Finland and determine factors that could influence SNS treatment outcomes. This is a national multicentre study, involving all patients tested for SNS implantation in Finland from 1999 to 2017. Data were collected retrospectively from electronic patient archives and analysed for possible effects on treatment outcome. Of the 432 patients with FI tested for SNS, 365 were women. Three hundred and thirteen (72.5%) of the tested patients advanced to permanent implantation of a stimulator. A successful final treatment outcome, with subjective alleviation of FI, was reported by 59.3% of the patients at the end of follow-up (mean 2.4 years, range 8 days to 13.3 years). Patients with obstetric sphincter injury and idiopathic FI had more permanent stimulator implantations than patients with iatrogenic injury (P = 0.012). Male patients had significantly worse test phase outcomes than female patients (P < 0.001). Age did not influence treatment outcome (P = 0.446) CONCLUSION: Subjective final success of SNS treatment for FI was achieved in 59.3% of patients at a mean of 2.4 years. Gender and the aetiology of FI influenced the test phase and final treatment outcome of SNS treatment.

Identifiants

pubmed: 30192431
doi: 10.1111/codi.14406
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

59-65

Informations de copyright

Colorectal Disease © 2018 The Association of Coloproctology of Great Britain and Ireland.

Auteurs

J Kirss (J)

Division of Digestive Surgery and Urology, Turku University Hospital, Turku, Finland.
University of Turku, Turku, Finland.

T Pinta (T)

Department of Surgery, Seinäjoki Central Hospital, Seinäjoki, Finland.

P Varpe (P)

Division of Digestive Surgery and Urology, Turku University Hospital, Turku, Finland.

T Rautio (T)

Oulu University Hospital, Oulu, Finland.

M Kairaluoma (M)

Central Finland Central Hospital, Jyväskylä, Finland.

M Hyöty (M)

Tampere University Hospital, Tampere, Finland.

S Hurme (S)

University of Turku, Turku, Finland.
Department of Biostatistics, University of Turku, Turku, Finland.

C Böckelman (C)

Helsinki University Hospital, Helsinki, Finland.

V Kairaluoma (V)

Oulu University Hospital, Oulu, Finland.

S Salmenkylä (S)

Helsinki University Hospital, Helsinki, Finland.

M Victorzon (M)

University of Turku, Turku, Finland.
Department of Surgery, Vaasa Central Hospital, Vaasa, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH